The chemical antagonist of the MEK pathway, PD184161, was used to block TLR signal transduction during infection of THP-1 macrophages with either ΔyopBY. enterocolitica or YopJC172A Y. pseudotuberculosis. Here, MAP2K7 is linked to infection.